North America Intraocular Lenses Market By Type

Growth Outlook

• The North America Intraocular Lenses Market By Type market is on a steady long-term growth path. Segment value stands at roughly USD 1708 Mn in 2026 and is projected to reach USD 1809 Mn by 2027 — a gain of about 6% over the forecast period, translating to a CAGR in the mid-single digits.
• What the regional split looks like (2026): Traditional/Monofocal IOLs leads, holding roughly 57% of segment value — the single largest regional share. Multifocal IOLs is the second-largest contributor. Toric, Extended Depth-Of-Focus (EDoF) IOLs , Accommodating IOLs and Phakic IOLs make up the remainder, in descending order.
• By 2027, Traditional/Monofocal IOLs alone is expected to reach USD 1028 Mn, with Multifocal IOLs at USD 334 Mn.

Market Dynamics

The intraocular lenses (IOLs) market in North America is expected to witness significant growth in the coming years due to factors such as the rising prevalence of cataract and other age-related eye diseases, advancements in technology, and increasing adoption of minimally invasive surgeries.

Cataract is the leading cause of vision loss in North America, affecting millions of people across the region. According to the American Academy of Ophthalmology, nearly 24.4 million Americans aged 40 and above are affected by cataract. This high prevalence of cataract has led to an increase in the demand for IOLs, which are used to replace the eye's natural lens during cataract surgery. Moreover, with the growing geriatric population in North America, the burden of age-related eye diseases is also increasing, further propelling the demand for IOLs in the region.

Advancements in technology have also played a crucial role in the growth of the IOLs market in North America. The development of premium IOLs, which provide improved visual outcomes and reduce the need for glasses or contact lenses after cataract surgery, has been a major driver of market growth. Additionally, the adoption of advanced technologies, such as femtosecond lasers, for cataract surgery has further increased the demand for IOLs in the region.

Minimally invasive surgeries, including micro-incision cataract surgery (MICS), have gained significant popularity in North America in recent years. These surgeries use smaller incisions, resulting in faster recovery and reduced risk of complications. This has led to an increased preference for IOLs that can be implanted through small incisions, such as foldable IOLs and multifocal IOLs.

The North America IOLs market is highly competitive, with a large number of players operating in the region. Major market players are focusing on product innovation, strategic partnerships, and mergers and acquisitions to gain a competitive edge. For instance, in 2019, Bausch + Lomb launched an extended depth of focus IOL in the US market, which provides near, intermediate, and distance vision without the need for glasses or contact lenses.

In conclusion, the North America IOLs market is expected to witness significant growth in the coming years, driven by the rising prevalence of cataract and other age-related eye diseases, technological advancements, and increasing adoption of minimally invasive surgeries. However, challenges such as high costs associated with premium IOLs and lack of awareness about cataract and available treatments in certain regions may hinder market growth to some extent.